UMC
02560.300 ↑
0.300 ↑
0.005 (1.7%)| High | 0.300 |
| Low | 0.290 |
| Open | 0.295 |
| Volume | 184,400 |
| Volume (B/S) | 294,700 / 60,900 |
| Price Bid/Ask | 0.290 / 0.300 |
| 52w | 0.280 - 0.475 |
| ROE | 8.88 |
| P/E | 14.54 |
| EPS | 2.06 |
| DPS | 0.30 |
| DY | 1.00% |
| NTA | 0.2319 |
| P/B | 1.29 |
| RPS | 15.70 |
| PSR | 1.91 |
| Market Cap | 112.2M |
| Shares (mil) | 373.91 |
| RTopQ RQoQ RYoY |
| CAGR |
3Y
6370%
TTM
-923%
5Y
-5282%
TTM
3470%
|
|
| RSI(14) | Neutral 46.0 |
| Stochastic(14) | Neutral 60.0 |
| Stochastic RSI(14) | Neutral 39.0 Sell |
| Average Volume (3M) | 122,600 |
| Relative Volume | 1.4 |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jul, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 Jan 2026 | 31 Jul 2026 | First Interim Dividend | 29 Jan 2026 | 10 Feb 2026 | 0.0030 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
UMediC poised for solid near-term revenue visibility
UMediC Group Bhd's order book rose 17% quarter-on-quarter to RM18mil as at July, providing solid near-term revenue visibility as the group targets a 10% to 15% capacity expansion in the financial year 2027 (FY27).TheStar -
【行家论股】需求持续增长 UMediC扩张医疗业务
UMediC集团2026财年营业额达5870万令吉,同比增加20.8%,主要由市场营销及分销业务带动。...Nanyang -
Distribution growth to underpin UMediC’s FY27 earnings
Rising plastic input costs may weigh on UMediC Group Bhd's (UMC) near-term outlook, but analysts expect its earnings to strengthen in financial year 2027 (FY27), led by the distribution division.TheStar -
UMediC’s quarterly revenue up 52% to RM18.7mil
PETALING JAYA: UMediC Group Bhd expects its expanded manufacturing capabilities and growing exposure to specialised healthcare segments to support its next phase of growth after fourth-quarter revenue jumped 52.1% year-on-year to RM18.7mil.TheStar -
销售成本走高 UMediC集团末季少赚19%
(吉隆坡14日讯)归咎于销售成本走高,UMediC集团(UMC,0256,主板医疗保健组)截至2026年7月31日第四季净利减少18.53%,至203万1000令吉,拉低全年净利5.14%,至771万5000令吉。在行销与分销业务推动下,该公司末季营业额增长52.05%,至1868万7000令吉,推高全年营业额20.84%,至5868万5000令吉。展望未来,UMediC集团透过文告指出,在大马政府持续承诺提升国家医疗保健系统下,集团有望从医疗设施升级需求增长、医疗旅游扩张及缓解政府医院拥挤...Sinchew
Recent Announcements
-
Quarterly rpt on consolidated results for the financial period ended 31/07/2026
-
Quarterly rpt on consolidated results for the financial period ended 30/04/2026
-
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Commencement of Members' Voluntary Winding Up of Subsidiary -
Quarterly rpt on consolidated results for the financial period ended 31/01/2026
-
OTHERS
UMEDIC GROUP BERHAD ("UMC" OR "COMPANY") PROPOSED LEASE OF LAND